Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride treatment changes urine metabolomics and steroid signatures, potentially monitoring effectiveness but may cause sexual side effects.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

The document concludes that more research is needed to fully understand the causes of PCOS.

The document concludes that Rabson-Mendenhall syndrome requires novel treatments for insulin resistance and emphasizes the importance of dental care in affected patients.

The protein StAR is found in 17 different organs and can affect hair loss and brain functions, but its full role is not yet fully understood.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

Pregnenolone might help manage movement issues caused by Parkinson's disease treatment without reducing the medicine's effectiveness.

Medications for PCOS don't seem to raise heart disease risk.

A 70-year-old woman with a malignant adrenal tumor improved after surgery and radiotherapy.

Finasteride for hair loss may cause persistent sexual symptoms, depression, anxiety, and lower quality of life.

Young girls whose mothers have PCOS may have higher activity of a specific enzyme that could lead to developing PCOS later.

Testosterone therapy is beneficial for women's health and does not cause masculinization or liver damage, and it protects the heart and breasts.

The document concludes that various drugs for men's health issues are in development, with treatments for sexual dysfunction and prostate conditions being the most advanced.

The document explains how male reproductive hormones work and affect the body.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

Addressing underrepresentation in Parkinson's research is crucial for better treatments and understanding.

SHBG binding properties are unchanged in male liver cirrhosis patients.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Women with PCOS have lower adiponectin hormone levels and are more likely to have insulin resistance.

Lower SHBG levels may increase the risk of PCOS.

Androgens are important for normal ovarian function and estrogen production, but may not be the main cause of follicle death.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

Allopregnanolone can reduce gut inflammation and normalize neurotransmitter levels after finasteride withdrawal.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

Statins may help treat PCOS by lowering androgen levels and improving cholesterol.

Blocking androgen activity in newborn rats affects body weight and appetite-related hormones differently in males and females.